상단 이벤트
초기 개발 단계에서 임상 단계로의 원활한 전환과 일관된 제품 품질 및 성능 제공
최적의 셀 확장 및 분화를 보장하는 뛰어난 배치 간 일관성
해당 GMP 지침을 준수하여 제조되었습니다.
(GMP 제품에 대한 규제 지원 제공)
| Attributes | Preclinical Grade | GMP Grade |
|---|---|---|
| Intended use | Intended for preclinical ex vivo use | Intended for clinical ex vivo use and manufacturing of Cell and Gene Therapy products |
| Volume | 50 µg | 50 µg and 1 mg for selected cytokines |
| Access to batch documentation | No | Yes |
| Identity of product confirmed | One method | ≥ two methods |
| Activity value on CoA | Minimum | Specific |
| Regulatory support, DMF, on-site audits, change notifications, etc |
No | Yes |
| Regulatory compliance | USP <1043>, Ph. EUR 5.2.12 | USP <1043>, Ph. EUR 5.2.12, ISO 20399:2022 |
Note: T cells play a central role in cell-mediated immunity. Immunotherapy based on these powerful cells is a rapidly growing field with promising results.
Current therapies use one of the four following technologies: chimeric antigen receptor (CAR) bearing T cells, tumor-infiltrating lymphocytes (TILs),
regulatory T cells (Treg) and T cell receptor (TCR) engineered T cells.
| Growth Factors & Cytokines | Format | Amount | Quantity | Order Number |
|---|---|---|---|---|
| CellGenix® Preclinical rh Activin A | Lyophilized, glass vial | 50 µg | 1 | 1422-050 |
| CellGenix® GMP rh Activin A | Lyophilized, glass vial | 50 µg | 1 | 1022-050 |
| CellGenix® Preclinical rh EGF | Lyophilized, glass vial | 50 µg | 1 | 1416-050 |
| CellGenix® GMP rh EGF | Lyophilized, glass vial | 50 µg | 1 | 1016-050 |
| CellGenix® GMP rh EGF | Lyophilized, glass vial | 1 µg | 1 | 1016-1000 |
| CellGenix® Preclinical rh FGF-2 | Lyophilized, glass vial | 50 µg | 1 | 1421-050 |
| CellGenix® GMP rh FGF-2 | Lyophilized, glass vial | 50 µg | 1 | 1021-050 |
| CellGenix® GMP rh FGF-2 | Lyophilized, glass vial | 1 µg | 1 | 1021-1000 |
| CellGenix® Preclinical rh FLt-3L | Lyophilized, glass vial | 50 µg | 1 | 1415-050 |
| CellGenix® GMP rh FLt-3L | Lyophilized, glass vial | 50 µg | 1 | 1015-050 |
| CellGenix® GMP rh FLt-3L | Lyophilized, glass vial | 1 µg | 1 | 1015-1000 |
| CellGenix® Preclinical rh GM-CSF | Lyophilized, glass vial | 50 µg | 1 | 1412-050 |
| CellGenix® GMP rh GM-CSF | Lyophilized, glass vial | 50 µg | 1 | 1012-050 |
| CellGenix® GMP rh GM-CSF | Lyophilized, glass vial | 1 µg | 1 | 1012-1000 |
| CellGenix® Preclinical rh IFN-γ | Lyophilized, glass vial | 50 µg | 1 | 1425-050 |
| CellGenix® Preclinical rh IL-10 | Lyophilized, glass vial | 50 µg | 1 | 1414-050 |
| CellGenix® GMP rh IL-10 | Lyophilized, glass vial | 50 µg | 1 | 1014-050 |
| CellGenix® Preclinical rh IL-12 | Lyophilized, glass vial | 50 µg | 1 | 1428-050 |
| CellGenix® Preclinical rh IL-15 | Lyophilized, glass vial | 50 µg | 1 | 1413-050 |
| CellGenix® GMP rh IL-15 | Lyophilized, glass vial | 50 µg | 1 | 1013-050 |
| CellGenix® Preclinical rh IL-18 | Lyophilized, glass vial | 50 µg | 1 | 1429-050 |
| CellGenix® Preclinical rh IL-1β | Lyophilized, glass vial | 50 µg | 1 | 1411-050 |
| CellGenix® GMP rh IL-1β | Lyophilized, glass vial | 50 µg | 1 | 1011-050 |
| CellGenix® Preclinical rh IL-2 | Lyophilized, glass vial | 50 µg | 1 | 1420-050 |
| CellGenix® GMP rh IL-2 | Lyophilized, glass vial | 50 µg | 1 | 1020-050 |
| CellGenix® GMP rh IL-2 | Lyophilized, glass vial | 1 µg | 1 | 1020-1000 |
| CellGenix® Preclinical rh IL-21 | Lyophilized, glass vial | 50 µg | 1 | 1419-050 |
| CellGenix® GMP rh IL-21 | Lyophilized, glass vial | 50 µg | 1 | 1019-050 |
| CellGenix® Preclinical rh IL-3 | Lyophilized, glass vial | 50 µg | 1 | 1402-050 |
| CellGenix® GMP rh IL-3 | Lyophilized, glass vial | 50 µg | 1 | 1002-050 |
| CellGenix® Preclinical rh IL-4 | Lyophilized, glass vial | 50 µg | 1 | 1403-050 |
| CellGenix® GMP rh IL-4 | Lyophilized, glass vial | 50 µg | 1 | 1003-050 |
| CellGenix® GMP rh IL-4 | Lyophilized, glass vial | 1 µg | 1 | 1003-1000 |
| CellGenix® Preclinical rh IL-6 | Lyophilized, glass vial | 50 µg | 1 | 1404-050 |
| CellGenix® GMP rh IL-6 | Lyophilized, glass vial | 50 µg | 1 | 1004-050 |
| CellGenix® GMP rh IL-6 | Lyophilized, glass vial | 1 µg | 1 | 1004-1000 |
| CellGenix® Preclinical rh IL-7 | Lyophilized, glass vial | 50 µg | 1 | 1410-050 |
| CellGenix® GMP rh IL-7 | Lyophilized, glass vial | 50 µg | 1 | 1010-050 |
| CellGenix® Preclinical rh OSM | Lyophilized, glass vial | 50 µg | 1 | 1423-050 |
| CellGenix® Preclinical rh PDGF-BB | Lyophilized, glass vial | 50 µg | 1 | 1409-050 |
| CellGenix® GMP rh PDGF-BB | Lyophilized, glass vial | 50 µg | 1 | 1009-050 |
| CellGenix® GMP rh SCF | Lyophilized, glass vial | 50 µg | 1 | 1018-050 |
| CellGenix® GMP rh SCF | Lyophilized, glass vial | 1 µg | 1 | 1018-1000 |
| CellGenix® Preclinical rh SCF | Lyophilized, glass vial | 50 µg | 1 | 1418-050 |
| CellGenix® Preclinical rh TGF-β1 | Lyophilized, glass vial | 50 µg | 1 | 1426-050 |
| CellGenix® GMP rh TGF-β1 | Lyophilized, glass vial | 50 µg | 1 | 1026-050 |
| CellGenix® Preclinical rh TNF-α | Lyophilized, glass vial | 50 µg | 1 | 1406-050 |
| CellGenix® GMP rh TNF-α | Lyophilized, glass vial | 50 µg | 1 | 1006-050 |
| CellGenix® Preclinical rh TPO | Lyophilized, glass vial | 50 µg | 1 | 1417-050 |
| CellGenix® GMP rh TPO | Lyophilized, glass vial | 50 µg | 1 | 1017-050 |
| CellGenix® GMP rh TPO | Lyophilized, glass vial | 1 µg | 1 | 1017-1000 |
